Extracellular acidification rates (ECAR) response of C3A liver cells to aspalathin (10 μM), glucose (10 mM), oligomycin (1 μM) and 2-deoxyglucose (2-DG) (100 mM), respectively (A). Individual parameters for glycolysis, glycolytic capacity, glycolytic reserve of C3A liver cells after aspalathin treatment (B and C), and the effect of palmitate and aspalathin on OCAR/ECAR (D). ECAR was measured under basal conditions followed by the sequential addition of aspalathin (10 μM), glucose (10 mM), oligomycin (1 μM), and 2-deoxyglucose (2-DG) (100 mM) the order was as follows (aspalathin>Glu > Oli > 2-DG). Data are expressed as means ± SEM, n = 3 independent experiments. **** p #### p < 0.0001 versus palmitate control.</p
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
In the pursuit of bioactive phytochemicals as a therapeutic strategy to manage metabolic risk factor...
The effect of aspalathin on metabolic activity in insulin-resistant C3A liver cells, as measured by ...
The effect of aspalathin on glucose uptake (A), glucose 2 protein expression (B), and palmitate upta...
Chemical structure of aspalathin (A), dose dependent effect of aspalathin on improving glucose uptak...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
The effect of aspalathin on protein kinase B (AKT) protein expression (A), and phosphatidylinositol-...
The graph shows oxygen consumption rate of all treatments (OCR) (A), individual parameters for basal...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
In the pursuit of bioactive phytochemicals as a therapeutic strategy to manage metabolic risk factor...
The effect of aspalathin on metabolic activity in insulin-resistant C3A liver cells, as measured by ...
The effect of aspalathin on glucose uptake (A), glucose 2 protein expression (B), and palmitate upta...
Chemical structure of aspalathin (A), dose dependent effect of aspalathin on improving glucose uptak...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
The effect of aspalathin on protein kinase B (AKT) protein expression (A), and phosphatidylinositol-...
The graph shows oxygen consumption rate of all treatments (OCR) (A), individual parameters for basal...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its e...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
Natural compounds may bear promising therapeutic benefits against metabolic diseases such as type 2 ...
In the pursuit of bioactive phytochemicals as a therapeutic strategy to manage metabolic risk factor...